Foreign institutional investors (FIIs) have raised shareholding in Dr Reddy's Laboratories, an integrated global pharmaceutical company. FIIs' shareholding increased by 312 basis points to 38.41 percent at the end of September 2014 quarter from 35.29 percent as on Jun. 30, 2014.
However, domestic institutional investors (DIIs) have reduced shareholding in the company. DIIs' shareholding decreased by 5 basis points to 5.38 percent at the end of September 2014 quarter from 5.43 percent as on Jun. 30, 2014.
Non Institutions were holding 13.68 percent stake at the end of September 2014 quarter, down 165 basis points from 15.33 percent as on Jun. 30, 2014.
Corporate bodies were holding 4.55 percent stake at the end of September 2014 quarter, down 126 basis points from 5.81 percent as on Jun. 30, 2014.
